OncoResponse nabs $7 mln
Houston-based OncoResponse, an immuno-oncology antibody discovery company, has raised $7 million in Series A financing. The investors were GreatPoint Ventures and Helsinn Investment Fund.
10 October 2016•1 min read
Houston-based OncoResponse, an immuno-oncology antibody discovery company, has raised $7 million in Series A financing. The investors were GreatPoint Ventures and Helsinn Investment Fund.
